chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vials were initialy stored in refrigerator on 29-March-2022, which was expired on 17-March-2022, and administered on 30-March-2022; Expired dose administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered) and PRODUCT STORAGE ERROR (Vials were initialy stored in refrigerator on 29-March-2022, which was expired on 17-March-2022, and administered on 30-March-2022) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vials were initialy stored in refrigerator on 29-March-2022, which was expired on 17-March-2022, and administered on 30-March-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered) and PRODUCT STORAGE ERROR (Vials were initialy stored in refrigerator on 29-March-2022, which was expired on 17-March-2022, and administered on 30-March-2022) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.   The vials were stored in refrigerator on 29-Mar-2022.  It was reported that the vails, were shipped out to vaccine facility were expired. The vails did not undergo temperature excursion.  At the time of reporting no adverse reaction was reported by the patient.  No treatment medication information was given.
Pt received vaccine on 05/15/1996 and on this date 8/23/04 with a mild case of chicken pox.
Patient was administered expired Adacel vaccine (expiration date was 6/18/2023, administered on 6/22/2023) Patient was administered meningococcal B (bexsero) instead of meningococcal A
first dose bnt162b2 on 02Apr2021/ tested positive for COVID virus on 06Apr2021; This is a spontaneous report from a Pfizer sponsored program. A female patient reported for herself, received the first dose bnt162b2 (Batch/Lot number was not reported) on 02Apr2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was tested positive for COVID virus on 06Apr2021, wondering if she was able to get the second dose. The outcome of the event is unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 73-year-old male patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. Concurrent medical conditions included atrial fibrillation. On 14th June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. On 14th June 2018, immediately after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced pain in arm. In June 2018, the patient experienced muscle pain. On an unknown date, the patient experienced incomplete course of vaccination. The patient was treated with steroids nos (Steroid (Not Specified)). On an unknown date, the outcome of the pain in arm was recovering/resolving and the outcome of the muscle pain was not recovered/not resolved and the outcome of the incomplete course of vaccination was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. The reporter considered the muscle pain to be related to SHINGRIX. Additional details were provided as follows: The patient got a sore arm right away post vaccination with SHINGRIX. His sore arm was not that bad. About a week and a half to two weeks later, the patient came down with muscle pain in the back of the leg, butt, arms, across his neck, across his shoulders. The patient did not know if it was his atrial fibrillation that he had prior to SHINGRIX, so he changed medication and that did not take the pain away. He finally started receiving steroid shots to help him cope with the pain. The patient has not had any formal diagnosis but he was going back to the physician for blood test. The reporter was upset because she felt like the SHINGRIX activated this on both herself and her husband. The patient was late in receiving the 2nd dose of the SHINGRIX. The patient would not get the 2nd dose until it has been confirmed that SHINGRIX might not have caused these symptoms. The reporter did not consent to follow-up. This case has been linked to the case US2019004812, reported by same reporter for husband.
Patient developed onset of right parascapular pain on 12/2/00. He had onset of right hand weakness and incoordination on 12/6/00. Specifically, he had weakness of the thumb and abduction of fingers with decreased pinch and grip strength. Tentative diagnosis is brachial plexitis.
After receiving shingles vaccine I came down with painful case of shingles. Started to spread over neck, shoulder and on back. Went to Doctor confirmed it was shingles and gave me valacyclovir HCl 500 mg 1 tablet 3 x day. Improved slowly over next week or 2 weeks less painful with movement.
VR described dizziness and light headedness.  VR presented diaphoretic and pale minutes after vaccination. no hx of syncope with vaccinations in past.
pain at the injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at the injection site) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE PAIN (pain at the injection site) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Redness/pain at injection site, pain radiates to upper shoulder starting night of vaccination, not resolved @ 72 hours. Fever, body aches, chills starting night of vaccination and lasting ~30 hours.
mild stomach pains-h/a-no fever; starting 36 hr sp/vax; lasitng until next am;
Prolonged coughing over a 2 week period; checked at Urgent Care twice, one chest X-ray show nothing. Cough not resolved w' asperator or cough drops. Cough worsens, EMT's called 7/13/21. Emergency Room orders Cat Scan, blood clots found in lungs; MRI finds lots in legs. Patient is a physically fit male, 81. Received Pfizer shots 01/20/21 and 2/10/21. In hospital 5 days, is on oxygen and Xarlto . Follow up w/ primary, Dr could not confirm suspicions that Covid shots caused blood clots.
Pain at injection site immediately after injection. Then the painful area kept getting worse and larger. Currently, the front and back of right upper arm and shoulder are very painful, 100% of the time, especially with movement of the shoulder joint, even passive movement. Also, front of chest is painful all the time, worse with movement of right arm and shoulder, and upper thoracic spine on right is painful all the time, worse with movement. The whole area is much more sensitive to touch than before the shot.
Swelling in face and neck, Redness in face and neck, Ears warm, Deepening of voice,. I noticed the symptoms half an hour after the shot, and cleared up with 3 hours.
@ 7PM 4JUN97 mom noticed rash on both legs-states carried pt to ER-states MD said probably d/t immun-states pt given DPH by mouth;no meds given-to take home;states rash gone by next morning;
Pt had a high fever, diarrhea, loss of appetite and headache (approx 3 days).
Pt recvd 3 doses of Engerix-B & 9DEC91 it was determined that pt did not respond to the vax series;
got tested and tested positive; got tested and tested positive; lethargic; This is a spontaneous report from non-contactable consumer. This consumer reported similar events for two patients (husband and wife). This is the first of two reports (for the wife).  A 72-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration on 04Jan2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, reported as two days after, the patient was lethargic. A week ago on an unspecified date, reported as past Monday, she had no cough, no fever, received azithromycin, got tested and tested positive. She wanted to know if they can receive the second dose and the timing of the second dose of vaccine. The patient underwent laboratory tests and procedures which included SARS-CoV-2 test: positive on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are possible. Information about the lot/batch cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021046180 same drug/event, different patient
Patient tested positive for COVID 7/12/21. She is fully vaccinated. Asymptomatic.
complains of generalized malaise arthralgias and myalgias. complaint that her husband gave her COVID not normally on supplemental oxygen and her oxygen level per EMS was 85%.  In the room it is 90% with a good waveform.  She is also tachycardic at 105.
I had my first shingles vaccine in December 2020; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose in an unknown date of December 2020).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The case was self reported by the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. Follow up would not be possible as contact details were not provided.
Left arm red, painful, and swollen after receiving pneumovax injection on 11/1/05. Afebrile. Pain with movement. No SOB, hives, or tongue swelling.
Woke up at around 3:10 am this am with extreme chills and body aches.  Had a temperature of 101.4 and felt awful.  Took some ibuprofen (didnt have any tylenol) turned the heat up to 76 and at this time (7:54) am I feel a little better but I stil have a temperature of 101.2. I'm just sending this for your information
Soreness, nausea, fainted leading to fall and minor injury (brusing of tailbone)
doses administered after more than 1 temperature excursion; doses administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021 at 8:43 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021 at 8:43 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 31-Mar-2021, Excursion time was 8 AM, temp was 32 , total doses given for the day was 199, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-MAR-2021. 19 vial was moved to clinic. Vaccine BUD date was 08-Apr-2021.  Vial was stored on cooler 1 , on 30-Mar-2021, Excursion duration At 8AM: 32 9 AM: 32, 10 AM: 40, 11 AM:42, 12 AM:43, 1PM : 44, 2 PM : 46, 3 PM: 46, 4 PM: 44 and 5 PM : 44  Concomitant products were not provided.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
fever 12SEP97;t100.8 to >100.3; prev wk before-Friday T101.3-102;sz to hosp transferred to another ER via amb;
R deltoid/bicep-red, hot to touch, sore muscle, increased pain with movement, red streak noted. Seeking med tx.
never followed up for 2nd dose; This case was reported by a other health professional and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received of shingrix vaccine in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not reported. The patient enquired about what was the recommended course of action for a patient who received first dose of Shingrix in 2019 and never followed up for 2nd dose. Till the time of reporting, the patient did not receive second dose, which led to incomplete course of vaccination. The follow up would not possible as contact information was not available.
SHORTNESS OF BREATH AT NIGHT'; OXYGEN SATURATION DROPPED DURING SLEEP; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, frequency one total administered on 15-MAR-2021 for prophylactic vaccination .The batch number was not reported and has been requested. No concomitant medications were reported. On Apr-2021 (around five weeks after vaccination) patient experienced shortness of breath at night and oxygen saturation was decreased during sleep. Laboratory data (dates unspecified) included: Oxygen saturation (NR: not provided) 86 percentage The action taken with covid-19 vaccine  was not applicable. The outcome of the shortness of breath at night' and oxygen saturation dropped during sleep was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: covid-19 vaccine shortness of breath, oxygen saturation decreased to 86%. This events are considered unassessable. The events have a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
Patient had reaction to shots give on 8/31/09. KINRIX 6x9 1/2 cm red and feverish whelp in right thigh no pain. VAIRIVAX 4x6cm left subq red feverish whelp, sore to touch.
ill for a few months; incomplete course of vaccination; This case was reported by a consumer via interactive digital media and described the occurrence of illness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In December 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 6 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced illness and incomplete course of vaccination. On an unknown date, the outcome of the illness was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the illness to be related to Shingrix.  Additional details were provided are as follows: The case was reported by patient for herself/himself. The age at vaccination was not reported for the 1sr dose and not applicable for the 2nd dose. The patient received a shot of Shingrix and at the 6 month mark when patient was due for 2nd shot was ill for a few months. As of today (on the day of reporting) the patient have not had his/her 2nd shot and asked that he/she need to start all over. The follow-up could not be possible as no contact details were available.
PATIENT WAS GIVEN HIB AND SHE WAS TO RECEIVE MENINGOCOCCAL CONJUG.
Numb lips, cheeks. Tongue, swollen throat Difficulty swallowing within 5min of shot,  Took 4 benedryl withi. 10min and drank 8oz of water.  Headed by car to hospital but symptoms were calming back down enroute.  That night pressure built in head. Lasted about 30days.
(SEVERE VERTIGO)     Day after injection, Swollen lymph node in armpit on injection side, went away after 3 days.   5 days after Lymph Node swelled back up even worse along with severe Vertigo.  Going on day 4 of everything spinning .
Pt. received vaccines, waited 15 minutes, denied any symptoms. While at check out, scheduling second HPV, stated "he was going to faint". By time receptionist got out of her chair, he fell backwards, hit head on wall, slid down wall. MA's came receptionist got Dr. BP, BS was done, pulse. He was in exam room for another 40 minutes before Dr released him. MA walked him to car.
I started experiencing symptomatic bradycardia. My heart rate has been in 40- 50 consistently I have been to ER twice because I have passed out. the electricity of my heart and chambers all looks fine. They can't figure out why all of sudden I developed bradycardia
16 Dec 2020 @1303: received dose at 0820, reports onset of chills and N/V sometime after 0900, >10 episodes, intermittent lightheadedness.  Also mid-sternal, non-radiating CP described as "burning and heaviness" that began approx. 6 min before ED arrival.  Given 1L NS IV, GI cocktail PO, and Zofran, Benadryl, Solumedrol, and Pepcid IVP.  Reported complete resolution of symptoms at 16 Dec 2020 @1529.
My period is always regular. My period was 6 days late, however, and I was extremely nervous about being pregnant. Luckily, I found this website (listed below) that has A LOT of posts about women's periods being SUPER late after getting the HPV Vaccine. You should really list this as a side effect, so women don't panic!!!!  http://www.steadyhealth.com/Gardarsil_shot__Late_period__Negative_Pregnancy_test__t108560.html
After receiving flu shot patient was walking away and another customer saw her fall to the ground. The pharmacist was notified and the patient was slighlty convulsing and after about a minute she became responsive and alert. She was not complaining of any pain anywhere. Paramedics were called and they took her vitals which were elevated and the patient was transferred to the hospital.
Information has been received from a registered pharmacist concerning a 67 year old female patient with hypertension and no drug reactions or allergies who on 10-JUN-2010 was vaccinated subcutaneously back of arm (unspecified which arm) with a 0.65 ml dose of ZOSTAVAX (Merck). Concomitant medication included unspecified blood pressure medication. The pharmacist stated that the patient was vaccinated on 10-JUN-2010 and 2 weeks later (on approximately 24-JUN-2010) called to pharmacist to report she had an itchy rash outbreak on one side of her face, eye and side of head, unspecified which side. Pharmacist suspected it could have been shingles. The patient recovered from the events. Lab diagnostics studies were not performed. Patient sought medical attention. Additional information has been requested.
5/18/21 patient presents to ER with complaint of Headache and Hypertension. The headache began on Sunday and become more intense. Patient felt like his forehead was swollen. Patient is compliant with blood pressure medication. Patient admitted to hospital for hypertensive emergency.
pt experienced arm numbess immediately after vaccine was administered. the numbness, which was described to travel down the nerve track in her right arm into her fingertips. the pt continued to flex her fingertips, massage the injection site, and rotate arm to lessen the numbness. We administered the pt oral diphenhydramine 12.5mg/5ml, she took 10 ml (25mg) upon request of the pt, to potentially minimize any risk of the contact dermatitis recurring with the second dose. The pt had diagnosis of contact dermatitis, a delayed reaction from her first moderna dose. it occurred 8 days post vaccine administration (treated with antihistamines and steroids).   the pt also self administered Tylenol 500mg while in the vaccine waiting area. The pt waited in the clinic area for 30 minutes post vaccination, and did not experience any change/worsening of symptoms.  The patient's brother drove her home. I contacted the pt. at 5:09 pm. to follow up with her symptoms. She stated the numbness was "not worse"  possibly starting to "ease up" but the numbness would continue in flares. she stated if felt like "she bumbed her funny bone". she took ibuprofen in the afternoon. she also left online message to notify her primary care physician, no response at this time.
Patient states he is having vision problems, feels weak and tired. I told him it was unlikely to be from the vaccines since they were given 16 days ago, however he is insistent he believes it is due specifically to the Havrix injection. He asked if he should go to the ER, I told him if he is having trouble breathing he should, he states he is having some difficulty breathing but did not mention that until I said it. I advised him if he is having trouble breathing to the point that he cannot, or just feels bad enough that he feels he should go, that he should.
2/13 tired, low stomach pain, arm sore, diaerhea. 5am all day 2/14 "         "                 "         "             "     headache 4pm 2/15 "     headache arm rash     "        pain in joints all day 2/16 "     arm rash itching         "          all day 2/17  "    body itching, pain in joints-all day 2/18 less tired, lower stomache pain , diarrhea   3am-5am 2/19 less tired, headache all day 2/20 less tired, late nite stomache ache
Moderate swelling of the axillary lymph node in the left arm and slight pain, on the second day after vaccination. Slight headache, chills and drowsiness from the day after vaccination.
After receiving Menomune SQ, patient became faint, shaky, c/o headache and nausea.  BP  115/73  P  78.  Routed to physician immediately.  Lungs clear. Vital signs 97.1-77-16  BP  121/75.  Dx:  mild adverse side effect Meningococcal vaccine.  Observed and released.
Chills, fever (up to 103F), loss of taste and smell, nerve tingling under skin, loss of appetite, severe headache   Symptoms subsided by 2/7/2021